Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation.

@article{Son2013EvaluationAM,
  title={Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation.},
  author={Yoen-Ju Son and Philip Worth Longest and Geng Tian and Michael Hindle},
  journal={European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  year={2013},
  volume={49 3},
  pages={
          390-9
        }
}
  • Yoen-Ju Son, P. Longest, M. Hindle
  • Published 14 June 2013
  • Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Figures and Tables from this paper

Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design
The objective of this study was to develop a new high-efficiency dry powder inhaler (DPI) that can effectively aerosolize large masses (25–100 mg) of spray dried powder formulations. The DPI was
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.
TLDR
An efficient inline DPI for delivering spray-dried formulations to children using positive pressure operation is proposed and initially developed, which may be beneficial for subjects who are too young to use a mouthpiece or to simultaneously treat the nasal and lung airways of older children.
Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
TLDR
This study evaluated the nose-to-lung delivery of excipient enhanced growth (EEG) formulation aerosols generated with a new inline dry powder inhaler (DPI) and found the best performing device contained a 2.3 mm flow control orifice and a 3D rod array with a 3-4-3 rod pattern.
Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
TLDR
The developed DPI produced high efficiency aerosolization with significant size increase of the aerosol within the airways that can be used to enable nose-to-lung delivery and aerosol administration during HFNC therapy.
Development of a High Efficiency Dry Powder Inhaler: Effects of Capsule Chamber Design and Inhaler Surface Modifications
TLDR
High efficiency performance is achieved for EEG delivery with the optimized DPI device and formulation combination producing an aerosol with MMAD and reduced the aerosol MMAD compared with commercial/modified DPIs.
Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.
TLDR
Use of a 3D rod array in the MP of a positive-pressure air-jet DPI was found to reduce aerosol size by 20%, not significantly increase MP depositional loss, reduce mouth-throat deposition by 6.4-fold and enable lung delivery efficiency as high as 73.4% of loaded dose based on pediatric test conditions.
Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.
High-efficiency dry powder inhalers (DPIs) were developed and tested for use with carrier-free formulations across a range of different inhalation flow rates. Performance of a previously reported DPI
Development and In Vitro Testing of a New High Efficiency Dry Powder Inhaler for Carrier-Free Formulations
TLDR
A high efficiency dry powder inhaler was developed and tested for use with carrier-free formulations across a range of different in vitro inhalation flow rates and produced an extremely high quality aerosol with little sensitivity to flow rate.
Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI.
TLDR
The inhaled antibiotic product nearly eliminated extrathoracic depositional loss, demonstrated high efficiency nose-to-lung antibiotic aerosol delivery in pediatric airway models for the first time, and provided high efficiency lung delivery efficiency with little variability across subject age and administered air volume.
...
...

References

SHOWING 1-10 OF 69 REFERENCES
Performance of Combination Drug and Hygroscopic Excipient Submicrometer Particles from a Softmist Inhaler in a Characteristic Model of the Airways
TLDR
Evaluated results indicated that EEG delivery of combination submicrometer particles could nearly eliminate MT deposition for inhaled pharmaceutical aerosols, and the proposed delivery approach represents a 1–2 order of magnitude reduction in MT deposition.
Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro.
  • T. Srichana, G. P. Martin, C. Marriott
  • Engineering
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 1998
New propellant-free technologies under investigation.
  • M. Dolovich
  • Medicine
    Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
  • 1999
Interest in the use of solution inhalers and dry powder inhalers (DPIs) has increased in recent years, broadening from systems for the delivery of traditional respiratory medications to the delivery
Targeting aerosol deposition to and within the lung airways using excipient enhanced growth.
TLDR
The trend of higher flow rates resulting in better alveolar delivery of aerosols is unique to EEG and may be used to design highly efficient dry powder inhalers.
Condensational Growth of Combination Drug-Excipient Submicrometer Particles for Targeted High Efficiency Pulmonary Delivery: Comparison of CFD Predictions with Experimental Results
TLDR
Enhanced excipient growth (EEG) appears to provide an effective technique to increase pharmaceutical aerosol size, and the developed CFD model will provide a powerful design tool for optimizing this technique to produce high efficiency pulmonary delivery.
The Role of Capsule on the Performance of a Dry Powder Inhaler Using Computational and Experimental Analyses
TLDR
The results suggested that impaction between the particles and the spinning capsule does not play a major role in powder dispersion, however, the capsule can provide additional strong mechanisms of deagglomeration dependent on the size of the capsule hole.
Evolution of dry powder inhaler design, formulation, and performance.
TLDR
A well-designed DPI and an appropriate powder formulation can optimize the effectiveness of inhaled drug therapy and recent advances in formulation technology can increase lung dose and reduce its variability.
...
...